Teladoc Health: Why Low Valuation Doesn't Equal A 'Buy' (Rating Downgrade) — Negative

TDOC   Seeking Alpha — January 21, 2026

Teladoc Health, Inc. is downgraded to Sell due to persistent revenue declines and deteriorating segment economics. TDOC's Q3 2025 revenue fell 2% year-over-year, with U.S. revenue down 5% and BetterHelp segment shrinking further. Free cash flow guidance was narrowed, and monetization per member is weakening, increasing exposure to visit-driven volatility.

image for news Teladoc Health: Why Low Valuation Doesn't Equal A 'Buy' (Rating Downgrade)

PLTR's Valuation is High: Not a Red Flag, if Execution Stays — Neutral

PLTR   Zacks Investment Research — January 21, 2026

PLTR's lofty valuation reflects confidence in execution, AI-driven software adoption and durable customers, if consistency continues.

image for news PLTR's Valuation is High: Not a Red Flag, if Execution Stays

BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System — Positive

BDX   Zacks Investment Research — January 21, 2026

BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.

image for news BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System

Beyond the Transatlantic Rift: Emerging Market Bond ETFs to Buy — Neutral

EMB  EMLC  VWOB   Zacks Investment Research — January 21, 2026

EMB and other EM bond ETFs are gaining favor as investors seek yield and insulation from US-EU trade tensions tied to the Greenland dispute.

image for news Beyond the Transatlantic Rift: Emerging Market Bond ETFs to Buy

SOFI's Operating Leverage is Finally Showing: What You Should Know — Positive

SOFI   Zacks Investment Research — January 21, 2026

Operating leverage is emerging at SoFi Technologies as expenses stabilize, revenues scale faster and the platform shifts toward scalable profitability.

image for news SOFI's Operating Leverage is Finally Showing: What You Should Know

Houlihan Lokey Expands Its European Business Through Two Deals — Positive

HLI   Zacks Investment Research — January 21, 2026

Houlihan Lokey expands its European footprint with two acquisitions, boosting advisory capabilities in France, Munich and London to support long-term growth.

image for news Houlihan Lokey Expands Its European Business Through Two Deals

Why Fifth Third Bancorp (FITB) is a Top Dividend Stock for Your Portfolio — Positive

FITB   Zacks Investment Research — January 21, 2026

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Fifth Third Bancorp (FITB) have what it takes?

image for news Why Fifth Third Bancorp (FITB) is a Top Dividend Stock for Your Portfolio

Why John Wiley & Sons (WLY) is a Top Dividend Stock for Your Portfolio — Positive

WLY   Zacks Investment Research — January 21, 2026

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes?

image for news Why John Wiley & Sons (WLY) is a Top Dividend Stock for Your Portfolio

Peoples Bancorp (PEBO) Could Be a Great Choice — Positive

PEBO   Zacks Investment Research — January 21, 2026

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Peoples Bancorp (PEBO) have what it takes?

image for news Peoples Bancorp (PEBO) Could Be a Great Choice

Why U.S. Bancorp (USB) is a Great Dividend Stock Right Now — Positive

USB   Zacks Investment Research — January 21, 2026

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does U.S. Bancorp (USB) have what it takes?

image for news Why U.S. Bancorp (USB) is a Great Dividend Stock Right Now

ATLANTA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against StubHub Holdings, Inc. (“StubHub” or the “Company”) (NYSE: STUB). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding StubHub's business, operations, and prospects, including allegations that: (1) StubHub was experiencing changes in the timing of payments to vendors; (2) those changes had a significant adverse impact on free cash flow, including trailing 12 months free cash flow; and (3) as a result, StubHub's free cash flow reports were materially misleading.

image for news Holzer & Holzer, LLC Reminds Investors of the January 23, 2026 Lead Plaintiff Deadline in the StubHub Holdings, Inc. (STUB) Securities Class Action – Investors With Significant Losses Encouraged to Contact the Firm

Blue Bird to Report Fiscal 2026 First Quarter Results on February 4, 2026 — Neutral

BLBD   Business Wire — January 21, 2026

MACON, Ga.--(BUSINESS WIRE)--Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and cleaner-emission school buses, will release its fiscal 2026 first quarter results on February 4, 2026. The public is invited to attend an audio webcast in which Blue Bird executives John Wyskiel, President and CEO, and Razvan Radulescu, CFO, will discuss results. This webcast will take place at 4:30PM ET on February 4, 2026. A slide presentation will be available to support the webcast. Dial-in details.

image for news Blue Bird to Report Fiscal 2026 First Quarter Results on February 4, 2026

Tesla's Earnings Could Be Much Better Than Expected — Positive

TSLA   Seeking Alpha — January 21, 2026

Tesla, Inc. remains a Strong Buy, with a $650 12-month price target, driven by leadership in EVs, AI, FSD, energy, and robotics. TSLA stock is entering a buy-in range of $420-380 after a 15% pullback, setting up for a potential run-up in 2026. Q4 sales are estimated at $26.45B, above consensus, with expected double beats on both revenue and EPS.

image for news Tesla's Earnings Could Be Much Better Than Expected

Energy ETFs in Spotlight With Gasoline Price Predicted to Drop in 2026 — Neutral

XLE   Zacks Investment Research — January 21, 2026

XLE and other energy ETFs are in focus after the EIA forecasted a 6% gasoline price drop in 2026, reshaping oil, refining and sector returns.

image for news Energy ETFs in Spotlight With Gasoline Price Predicted to Drop in 2026

Enbridge Shares Rally Toward 52-Week High: Buy the Strength or Wait? — Positive

ENB   Zacks Investment Research — January 21, 2026

ENB shares near a 52-week high, backed by take-or-pay contracts and a $35B project backlog. However, its valuation looks stretched.

image for news Enbridge Shares Rally Toward 52-Week High: Buy the Strength or Wait?

GBOOY vs. SOFI: Which Stock Is the Better Value Option? — Positive

GBOOY  SOFI   Zacks Investment Research — January 21, 2026

Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Grupo Financiero Banorte SAB de CV (GBOOY) and SoFi Technologies, Inc. (SOFI). But which of these two stocks is more attractive to value investors?

image for news GBOOY vs. SOFI: Which Stock Is the Better Value Option?

PAX vs. BLK: Which Stock Is the Better Value Option? — Positive

BLK  PAX   Zacks Investment Research — January 21, 2026

Investors interested in stocks from the Financial - Investment Management sector have probably already heard of Patria Investments (PAX) and BlackRock (BLK). But which of these two stocks presents investors with the better value opportunity right now?

image for news PAX vs. BLK: Which Stock Is the Better Value Option?

MoneyShow's Best Investment Ideas For 2026: Part 9 — Positive

GWW  TGT  TTD  UFPT  USAC  VZ  WLDN  WMB  WVE   Seeking Alpha — January 21, 2026

MoneyShow presents top investment ideas for 2026 from their contributors. This year's edition presents a mix of metals plays, financial stocks, deep value names, high-octane growth and tech stocks, and beaten-down REITs that offer solid income and turnaround potential. Part 9 of this series includes Target Corp., The Trade Desk, UFP Technologies, Verizon, and Williams Companies.

image for news MoneyShow's Best Investment Ideas For 2026: Part 9

AT&T: Where The Downtrend May End, Yield Climbing Toward 5% — Positive

T   Seeking Alpha — January 21, 2026

AT&T is rated a "Buy" due to compelling valuation and a 4.7% dividend yield after a 20%+ drawdown. Q3 results showed strong subscriber growth and free cash flow, but ARPU softness and high capex remain concerns. Management reaffirmed long-term guidance and slightly raised 2025 EPS targets, with 2026 EBITDA trimmed on competitive pressures.

image for news AT&T: Where The Downtrend May End, Yield Climbing Toward 5%

LOS ANGELES, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

image for news AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm